Chrysos Posts $66.1M Revenue and $16.1M EBITDA, Up 46% and 80% Respectively

Robust Financial Performance

Chrysos Corporation Limited (ASX – C79) has delivered a compelling FY25 trading update, showcasing significant growth across multiple metrics. The company reported unaudited total revenue of $66.1 million, marking a 46% increase over FY24’s $45.4 million. EBITDA surged by 80% to $16.1 million, reflecting improved operational efficiency and economies of scale. This performance was achieved despite ongoing audit delays related to international tax positions, with the company anticipating a tax expense between $5 million and $10 million.

Expanding Global Footprint

Central to Chrysos’ growth has been the accelerated deployment of its PhotonAssay technology, a cutting-edge solution for faster and more accurate gold analysis. During FY25, 11 new PhotonAssay units were installed, bringing the total deployed to 40 units globally. The company also signed nine new lease agreements, increasing contracted units to 59, with a further four agreements executed post year-end, pushing the total to 62. Notably, Chrysos secured a Master Services Agreement and initial lease with Newmont, the world’s leading gold miner, streamlining future deployments and signaling strong industry endorsement.

Strategic Partnerships and Market Penetration

Chrysos has broadened its reach through strategic partnerships with major laboratory groups including Bureau Veritas, SGS, and Intertek. These collaborations facilitate the deployment of PhotonAssay technology across key mining regions such as South America and Australia. The recent agreement with Bureau Veritas to install a unit in Antofagasta, Chile, and the delivery of the next-generation 'XN' unit to SGS’s Perth facility underscore Chrysos’ commitment to innovation and market expansion. Additionally, the partnership with Pantoro Gold at the Norseman Gold Mine exemplifies Chrysos’ tailored approach, combining direct-to-mine installations with laboratory operations.

Financial Strength and Outlook

Chrysos’ balance sheet remains robust, with $91.1 million in liquidity comprising cash on hand and undrawn debt facilities. The company’s capital expenditure of $63.2 million in property, plant, and equipment supports its aggressive deployment schedule, even as capital commitments have been reduced by 30% year-on-year. The Group generated positive operating cash flow of $8.8 million, enabling reinvestment in growth initiatives. Looking ahead, Chrysos has reaffirmed its FY26 guidance, projecting revenue between $80 million and $90 million and EBITDA ranging from $20 million to $27 million, signaling confidence in continued momentum.

Industry Impact and Future Prospects

Chrysos’ advancements in assay technology are reshaping gold analysis by delivering faster, safer, and more environmentally friendly solutions. The company’s expanding customer base, including top-tier miners and global laboratory giants, positions it well to capitalize on rising industry activity and sample volumes. CEO Dirk Treasure highlighted the company’s improved EBITDA margin of 24% and the growing adoption of PhotonAssay across four continents as key indicators of Chrysos’ strengthening market position. As the company prepares to release its audited FY25 results, investors will be watching closely to see how Chrysos navigates the final audit stages and executes on its ambitious growth plans.